ANI Pharmaceuticals Inc — Cash Flow (NASDAQ:ANIP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 15.27 M3.32 M-31.2 M118.96 M64.02 M185.22 M 185.22 M Cash from investing activities -68.32 M-105.48 M-15.74 M-18.51 M-404.72 M-34.32 M -34.32 M Cash from financing activities -1.44 M194.59 M-5.13 M67.44 M264.94 M-9.94 M -9.94 M Free cash flow -53.05 M-20.32 M-47.66 M100.45 M47.06 M150.9 M 150.9 M

News

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties

Is American Well (AMWL) Outperforming Other Medical Stocks This Year?

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa

ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset